• レポートコード:TPM-NV159 • 出版社/出版日:Transparency Market Research / 2019年10月28日 • レポート形態:英文、PDF、213ページ • 納品方法:Eメール • 産業分類:医療 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Global Site License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、神経血管塞栓デバイス(神経学)の世界市場について調べ、神経血管塞栓デバイス(神経学)の世界市場規模、市場動向、市場シェア、市場環境、市場予測、製品別(塞栓コイル、液体塞栓システム、分流ステント、動脈瘤クリップ、その他)分析、治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション)分析、疾患別(脳動脈瘤、動静脈奇形(AVM)、およびその他)分析、エンドユーザー別(病院、外来手術センター、専門クリニック)分析、関連企業情報などをまとめました。 ・神経血管塞栓デバイス(神経学)の市場概要 ・神経血管塞栓デバイス(神経学)の市場動向 ・神経血管塞栓デバイス(神経学)の世界市場規模・予測 ・神経血管塞栓デバイス(神経学)市場:製品別(塞栓コイル、液体塞栓システム、分流ステント、動脈瘤クリップ、その他) ・神経血管塞栓デバイス(神経学)市場:治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション) ・神経血管塞栓デバイス(神経学)市場:治療別(虚血性脳卒中ソリューションおよび出血性脳卒中ソリューション) ・神経血管塞栓デバイス(神経学)市場:エンドユーザー別(病院、外来手術センター、専門クリニック) ・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米) ・競争環境・関連企業分析 |
Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.
WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Regulatory Scenario
5.3. Reimbursement Scenario
5.4. Key Mergers & Acquisitions
5.5. Technological Advancements
6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
6.2.1. Embolization Coils
6.2.2. Liquid Embolic Systems
6.2.3. Flow Diversion Stents
6.2.4. Aneurysm Clips
6.2.5. Others
6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product
7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment
7.1. Introduction & Definition
7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
7.2.1. Ischemic Stroke Solution
7.2.2. Hemorrhagic Stroke Solution
7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment
8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication
8.1. Introduction
8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
8.2.1. Brain Aneurysms
8.2.2. Arteriovenous Malformation (AVM)
8.2.3. Others
8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication
9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User
9.1. Introduction
9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
9.2.1. Hospitals
9.2.2. Ambulatory Surgery Centers
9.2.3. Specialty Clinics
9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User
10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region
10.1. Introduction
10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region
11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
11.1. Introduction
11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
11.2.1. Embolization Coils
11.2.2. Liquid Embolic Systems
11.2.3. Flow Diversion Stents
11.2.4. Aneurysm Clips
11.2.5. Others
11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
11.3.1. Ischemic Stroke Solution
11.3.2. Hemorrhagic Stroke Solution
11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
11.4.1. Brain Aneurysms
11.4.2. Arteriovenous Malformation (AVM)
11.4.3. Others
11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Specialty Clinics
11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Treatment
11.7.3. By Indication
11.7.4. By End User
11.7.5. By Country/Sub-region
12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
12.1. Introduction
12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
12.2.1. Embolization Coils
12.2.2. Liquid Embolic Systems
12.2.3. Flow Diversion Stents
12.2.4. Aneurysm Clips
12.2.5. Others
12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
12.3.1. Ischemic Stroke Solution
12.3.2. Hemorrhagic Stroke Solution
12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
12.4.1. Brain Aneurysms
12.4.2. Arteriovenous Malformation (AVM)
12.4.3. Others
12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Specialty Clinics
12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Treatment
12.7.3. By Indication
12.7.4. By End User
12.7.5. By Country/Sub-region
13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
13.2.1. Embolization Coils
13.2.2. Liquid Embolic Systems
13.2.3. Flow Diversion Stents
13.2.4. Aneurysm Clips
13.2.5. Others
13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
13.3.1. Ischemic Stroke Solution
13.3.2. Hemorrhagic Stroke Solution
13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
13.4.1. Brain Aneurysms
13.4.2. Arteriovenous Malformation (AVM)
13.4.3. Others
13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Specialty Clinics
13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Treatment
13.7.3. By Indication
13.7.4. By End User
13.7.5. By Country/Sub-region
14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
14.2.1. Embolization Coils
14.2.2. Liquid Embolic Systems
14.2.3. Flow Diversion Stents
14.2.4. Aneurysm Clips
14.2.5. Others
14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
14.3.1. Ischemic Stroke Solution
14.3.2. Hemorrhagic Stroke Solution
14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
14.4.1. Brain Aneurysms
14.4.2. Arteriovenous Malformation (AVM)
14.4.3. Others
14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Specialty Clinics
14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Treatment
14.7.3. By Indication
14.7.4. By End User
14.7.5. By Country/Sub-region
15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
15.2.1. Embolization Coils
15.2.2. Liquid Embolic Systems
15.2.3. Flow Diversion Stents
15.2.4. Aneurysm Clips
15.2.5. Others
15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
15.3.1. Ischemic Stroke Solution
15.3.2. Hemorrhagic Stroke Solution
15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
15.4.1. Brain Aneurysms
15.4.2. Arteriovenous Malformation (AVM)
15.4.3. Others
15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
15.5.1. Hospitals
15.5.2. Ambulatory Surgery Centers
15.5.3. Specialty Clinics
15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Treatment
15.7.3. By Indication
15.7.4. By End User
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
16.2. Company Profiles
16.2.1. Medtronic plc
16.2.1.1. Company Description
16.2.1.2. Business Overview
16.2.1.3. Financial Overview
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Stryker Corporation
16.2.2.1. Company Description
16.2.2.2. Business Overview
16.2.2.3. Financial Overview
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
16.2.3.1. Company Description
16.2.3.2. Business Overview
16.2.3.3. Financial Overview
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. B.Braun Melsungen AG
16.2.4.1. Company Description
16.2.4.2. Business Overview
16.2.4.3. Financial Overview
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Penumbra, Inc.
16.2.5.1. Company Description
16.2.5.2. Business Overview
16.2.5.3. Financial Overview
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Acandis GmbH
16.2.6.1. Company Description
16.2.6.2. Business Overview
16.2.6.3. Financial Overview
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. BALT EXTRUSION
16.2.7.1. Company Description
16.2.7.2. Business Overview
16.2.7.3. Financial Overview
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Terumo Medical Corporation
16.2.8.1. Company Description
16.2.8.2. Business Overview
16.2.8.3. Financial Overview
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Boston Scientific Corporation
16.2.9.1. Company Description
16.2.9.2. Business Overview
16.2.9.3. Financial Overview
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Spartan Micro, Inc.
16.2.10.1. Company Description
16.2.10.2. Business Overview
16.2.10.3. Financial Overview
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis